Table: Fuji Pharmaceutical -Q1 group results
Feb 7 (Reuters)-
Fuji Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Dec 31, 2018 Dec 31, 2017 Sep 30, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 10.28 9.96 36.82
(+3.2 pct) (+11.5 pct) (-2.9 pct)
Operating 1.61 1.73 4.54
(-7.0 pct) (+35.4 pct) (+3.3 pct)
Recurring 1.53 1.82 4.51
(-16.0 pct) (+19.9 pct) (+0.8 pct)
Net 1.10 1.30 3.40
(-15.8 pct) (+20.7 pct) (+0.7 pct)
EPS 36.63 yen 43.48 yen 113.51 yen
Ann Div 29.00 yen
-Q2 div 28.00 yen 14.00 yen
-Q4 div 14.00 yen 15.00 yen
NOTE - Fuji Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T